Technical analysis of Femasys Inc. (FEMY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
Price Performance
| 1 month | +16.36% |
| 3 months | -36.63% |
| Year-to-date | -77.78% |
| 1 year | -64.10% |
| 3 years | -60.74% |
| 5 years | -98.20% |
52-Week Range
| 52-week High | $22.20 |
| 52-week Low | $2.02 |
| Avg Volume (90d) | 535K |
Technical Indicators
| SMA 50 | $2.99 |
| SMA 200 | $8.23 |
| Beta | -2.28 |
| 30-day Volatility (annualised) | 105.0% |
| Price vs SMA 50 | -14.5% |
| Price vs SMA 200 | -68.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $12.74 | |
| 2025-11 | $20.20 | +58.6% |
| 2025-12 | $11.52 | -43.0% |
| 2026-01 | $10.70 | -7.1% |
| 2026-02 | $11.40 | +6.5% |
| 2026-03 | $8.40 | -26.3% |
| 2026-04 | $7.30 | -13.1% |
| 2026-05 | $7.74 | +6.0% |
| 2026-06 | $4.18 | -46.0% |
| 2026-07 | $2.86 | -31.6% |
| 2026-08 | $3.43 | +19.9% |
| 2026-09 | $2.56 | -25.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $2.54 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Financial Health
| Piotroski F-Score | 3 |
| Altman Z-Score | -10.88 |